Header Logo

Connection

YOSHIO YAMAOKA to Salicylates

Back to Details
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Salicylates.
YOSHIO YAMAOKA
Connection Strength
0.214
Salicylates
  1. Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial). Sci Rep. 2024 04 18; 14(1):8986.
    View in: PubMed
    Score: 0.214
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.